Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Tafenoquine Succinate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,132Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1M/s. Piramal Enterprises Limited

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Piramal Pharma Solutions

    U.S.A
    PharmScience R&D
    Not Confirmed
    arrow

    Piramal Pharma Solutions

    U.S.A
    arrow
    PharmScience R&D
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Tafenoquine Succinate IH

    Date of Issue : 2022-06-29

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0123

    Address of the Firm : Sy. Nos. 7-70, 70/1 & 70/2, Digwal Village, Kohir Mandai, Sangareddy District, T...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Looking for 106635-81-8 / Tafenoquine Succinate API manufacturers, exporters & distributors?

    Tafenoquine Succinate manufacturers, exporters & distributors 1

    31

    PharmaCompass offers a list of Tafenoquine Succinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tafenoquine Succinate manufacturer or Tafenoquine Succinate supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tafenoquine Succinate manufacturer or Tafenoquine Succinate supplier.

    PharmaCompass also assists you with knowing the Tafenoquine Succinate API Price utilized in the formulation of products. Tafenoquine Succinate API Price is not always fixed or binding as the Tafenoquine Succinate Price is obtained through a variety of data sources. The Tafenoquine Succinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Tafenoquine Succinate

    Synonyms

    106635-81-8, Wr-238605, Tafenoquine succinate [usan], Tafenoquine (succinate), Dl5j0b8vss, 106635-81-8 (succinate)

    Cas Number

    106635-81-8

    Unique Ingredient Identifier (UNII)

    DL5J0B8VSS

    About Tafenoquine Succinate

    Tafenoquine Succinate is the succinate salt form of tafenoquine, an orally bioavailable 8-aminoquinoline derivative, with antimalarial activity. Although the mechanism is not completely understood, upon administration, tafenoquine inhibits the parasitic enzyme heme polymerase in the blood stages of the parasites. This inhibits the conversion of the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Tafenoquine is active against all the stages of Plasmodium species and is also active against the pre-erythrocytic liver stages of the parasites. This prevents the development of the erythrocytic forms of the parasite which are responsible for relapses in P. vivax malaria.

    Tafenoquine Succinate Manufacturers

    A Tafenoquine Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tafenoquine Succinate, including repackagers and relabelers. The FDA regulates Tafenoquine Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tafenoquine Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Tafenoquine Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Tafenoquine Succinate Suppliers

    A Tafenoquine Succinate supplier is an individual or a company that provides Tafenoquine Succinate active pharmaceutical ingredient (API) or Tafenoquine Succinate finished formulations upon request. The Tafenoquine Succinate suppliers may include Tafenoquine Succinate API manufacturers, exporters, distributors and traders.

    click here to find a list of Tafenoquine Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Tafenoquine Succinate WC

    A Tafenoquine Succinate written confirmation (Tafenoquine Succinate WC) is an official document issued by a regulatory agency to a Tafenoquine Succinate manufacturer, verifying that the manufacturing facility of a Tafenoquine Succinate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tafenoquine Succinate APIs or Tafenoquine Succinate finished pharmaceutical products to another nation, regulatory agencies frequently require a Tafenoquine Succinate WC (written confirmation) as part of the regulatory process.

    click here to find a list of Tafenoquine Succinate suppliers with Written Confirmation (WC) on PharmaCompass.

    Tafenoquine Succinate Manufacturers | Traders | Suppliers

    Tafenoquine Succinate Manufacturers, Traders, Suppliers 1
    68

    We have 1 companies offering Tafenoquine Succinate

    Get in contact with the supplier of your choice:

    1. Piramal Pharma Solutions
    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.